PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 154 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2017. The put-call ratio across all filers is 1.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $26,000 | -62.3% | 6,400 | -42.9% | 0.01% | -38.5% |
| Q3 2018 | $69,000 | -46.1% | 11,200 | -29.1% | 0.01% | -55.2% |
| Q2 2018 | $128,000 | +190.9% | 15,800 | +163.3% | 0.03% | +163.6% |
| Q1 2018 | $44,000 | -25.4% | 6,000 | -31.0% | 0.01% | +22.2% |
| Q2 2017 | $59,000 | -79.0% | 8,700 | -70.8% | 0.01% | -71.9% |
| Q1 2017 | $281,000 | -7.3% | 29,800 | -15.1% | 0.03% | -15.8% |
| Q4 2016 | $303,000 | +131.3% | 35,100 | +16.5% | 0.04% | +153.3% |
| Q1 2016 | $131,000 | -31.1% | 30,136 | -2.9% | 0.02% | -37.5% |
| Q4 2015 | $190,000 | +153.3% | 31,036 | +136.9% | 0.02% | +166.7% |
| Q3 2015 | $75,000 | – | 13,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 17,902,338 | $135,342,000 | 5.88% |
| TIGER MANAGEMENT L.L.C. | 1,288,454 | $9,741,000 | 1.91% |
| Phocas Financial Corp. | 1,047,181 | $7,917,000 | 0.69% |
| TUDOR INVESTMENT CORP ET AL | 2,370,503 | $17,921,000 | 0.62% |
| EAM Investors, LLC | 553,309 | $4,183,000 | 0.58% |
| Baker Brothers Advisors | 4,449,797 | $33,640,000 | 0.34% |
| TFS CAPITAL LLC | 463,740 | $3,506,000 | 0.33% |
| FEDERATED HERMES, INC. | 13,508,290 | $102,123,000 | 0.32% |
| Rotella Capital Management, Inc. | 36,473 | $276,000 | 0.24% |
| OXFORD ASSET MANAGEMENT LLP | 1,103,848 | $8,351,000 | 0.18% |